Compare VNDA & PLBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VNDA | PLBC |
|---|---|---|
| Founded | 2002 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.9M | 363.9M |
| IPO Year | 2005 | 2002 |
| Metric | VNDA | PLBC |
|---|---|---|
| Price | $5.81 | $55.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $14.90 | ★ $57.67 |
| AVG Volume (30 Days) | ★ 878.9K | 64.8K |
| Earning Date | 05-06-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 2.60% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.38 |
| Revenue | ★ $216,105,000.00 | N/A |
| Revenue This Year | $21.35 | $25.59 |
| Revenue Next Year | $37.40 | $5.15 |
| P/E Ratio | ★ N/A | $39.72 |
| Revenue Growth | ★ 8.72 | N/A |
| 52 Week Low | $4.14 | $39.70 |
| 52 Week High | $9.91 | $57.51 |
| Indicator | VNDA | PLBC |
|---|---|---|
| Relative Strength Index (RSI) | 39.80 | 59.01 |
| Support Level | $5.11 | $50.35 |
| Resistance Level | $6.73 | N/A |
| Average True Range (ATR) | 0.27 | 1.41 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 23.97 | 59.09 |
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Plumas Bancorp provides banking products and services in Northeastern California and Northwestern Nevada, offering a range of deposit products for commercial and retail customers, including checking, savings, money market accounts, time deposits, retirement accounts, and sweep accounts for businesses and public entities, along with digital banking services such as mobile and internet banking, remote deposit, and electronic funds transfers, as well as other customary banking services. Its loan portfolio comprises commercial real estate, commercial and industrial, consumer, agricultural, residential real estate, and construction and land development loans, and the company generates its revenue from loans and investment securities, with additional income from service fees.